Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors

Abroad (travel likely)Recruiting

Conditions

Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Breast Carcinoma · Prognostic Stage IV Breast Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Study coordinator (Agnieszka K. Witkiewicz) · Agnieszka.Witkiewicz@roswellpark.org · 716-845-1224
Contact: Principal Investigator (Agnieszka K. Witkiewicz)

Study leads

Agnieszka K Witkiewicz
Principal Investigator
Roswell Park Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Advanced Breast Carcinoma · Advanced Endometrial Carcinoma · Advanced Fallopian Tube Carcinoma

Abroad (travel likely)RecruitingPHASE1

Houston, United States

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

Anatomic Stage IV Breast Cancer AJCC v8 · Hormone Receptor Positive Breast Carcinoma · Metastatic Breast Carcinoma

Abroad (travel likely)RecruitingPHASE2

Duarte, United States · Irvine, United States

Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

Advanced Breast Carcinoma · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior

Breast Cancer

Abroad (travel likely)Recruiting

Chapel Hill, United States